Your browser doesn't support javascript.
loading
FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.
Da Silva, Jordan; Jouida, Amina; Ancel, Julien; Dalstein, Véronique; Routhier, Julie; Delepine, Gonzague; Cutrona, Jérôme; Jonquet, Antoine; Dewolf, Maxime; Birembaut, Philippe; Deslée, Gaëtan; Polette, Myriam; Nawrocki-Raby, Béatrice.
Afiliação
  • Da Silva J; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Jouida A; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Ancel J; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Dalstein V; CHU de Reims, Hôpital Maison Blanche, Service de Pneumologie, Reims, France.
  • Routhier J; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Delepine G; CHU de Reims, Hôpital Maison Blanche, Laboratoire de Pathologie, Reims, France.
  • Cutrona J; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Jonquet A; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Dewolf M; CHU de Reims, Hôpital Robert Debré, Service de Chirurgie Cardio-Vasculaire et Thoracique, Reims, France.
  • Birembaut P; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Deslée G; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
  • Polette M; CHU de Reims, Hôpital Maison Blanche, Service de Pneumologie, Reims, France.
  • Nawrocki-Raby B; INSERM, Université de Reims Champagne Ardenne, P3Cell UMR-S 1250, SFR CAP SANTE, Reims, France.
J Pathol ; 251(2): 187-199, 2020 06.
Article em En | MEDLINE | ID: mdl-32237123

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidrolases Anidrido Ácido / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidrolases Anidrido Ácido / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article